Results 151 to 160 of about 3,064,383 (240)

SAMBA: A novel method for fast automatic model building in nonlinear mixed-effects models. [PDF]

CPT Pharmacometrics Syst Pharmacol, 2022
Prague M, Lavielle M.
europepmc   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

FLASH-MM: fast and scalable single-cell differential expression analysis using linear mixed-effects models. [PDF]

Nat Commun
Xu C, Pouyabahar D, Voisin V, Heydari H, Bader GD.   +4 more
europepmc   +1 more source

Generalized linear mixed-effects models for studies using different sets of stimuli across conditions. [PDF]

Front Psychol, 2022
He S, Lee W.
europepmc   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

Molecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau, Lilian G. Zhai, Ryunosuke Hoshi, Zackary Rousseau, Abraam Zakhary, Yin Fang Wu, Rola M. Saleeb, Heyu Ni, Kelsie L. Thu   +8 more
wiley   +1 more source

Estimation of individual tree aboveground biomass of genetically diverse <i>Catalpa bungei</i> based on nonlinear mixed-effects models and UAV LiDAR data. [PDF]

Front Plant Sci
Fu X, Ma W, Chen Q, Fu L, Zhang M, Duan G, Zhang Y, Zheng Z, Wu C, Wang Q, Shun Y, Li P.   +11 more
europepmc   +1 more source

Pune GSH supplementation study: Analyzing longitudinal changes in type 2 diabetic patients using linear mixed-effects models. [PDF]

Front Pharmacol, 2023
Madathil AK, Ghaskadbi S, Kalamkar S, Goel P.   +3 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Correction: Comparing the ability of the IAT and of the SC-IAT to account for behavioral outcomes: a re-analysis using linear mixed-effects models. [PDF]

Front Psychol
Epifania OM, Anselmi P, Robusto E.
europepmc   +1 more source

Data quality control in longitudinal epidemiologic studies: conditional studentized residuals from linear mixed effects models for outlier detection in the setting of pediatric chronic kidney disease. [PDF]

Ann Epidemiol, 2023
Ng DK, Patel A, Cox C.
europepmc   +1 more source